oxybutynin has been researched along with Hypomelanosis in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To identify and characterize cases of chemical leukoderma, an underrecognized adverse event, associated with the methylphenidate transdermal system (MTS) reported to the US Food and Drug Administration Adverse Event Reporting System (FAERS)." | 1.46 | Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System. ( Brinker, A; Cheng, C; Diak, IL; La Grenade, L; Levin, RL, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeuchi, A | 1 |
| Egawa, G | 1 |
| Nomura, T | 1 |
| Kabashima, K | 1 |
| Cheng, C | 1 |
| La Grenade, L | 1 |
| Diak, IL | 1 |
| Brinker, A | 1 |
| Levin, RL | 1 |
2 other studies available for oxybutynin and Hypomelanosis
| Article | Year |
|---|---|
Contact leukoderma induced by rotigotine transdermal patch (Neupro®).
Topics: Dopamine Agonists; Female; Humans; Hypopigmentation; Middle Aged; Restless Legs Syndrome; Tetrahydro | 2019 |
Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Central Nervous System Stimulants; Child | 2017 |